Not currently recruiting at UCSF
A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804
a study on Osteogenesis Imperfecta
Osteogenesis Imperfecta, Type IOsteogenesis Imperfecta Type IIIOsteogenesis Imperfecta Type IVOsteogenesis ImperfectaBrittle Bone DiseaseBPS804BPS804 Dose 1BPS804 Dose 2BPS804 Dose 3BPS804 Dose 4
Lead Scientist at UCSF
- Andrew Burghardt
Andrew Burghardt is a Research Specialist in the Department of Radiology and Biomedical Imaging at University of California, San Francisco where he serves as the Technical Director of the Quantitative Micro-Imaging Facility (QMIF). His area of expertise is high-resolution imaging computational analysis of musculoskeletal tissues.